| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $466.1M | +10.5% |
| Cost of Revenue | $80.7M | +18.3% |
| Gross Profit | $385.5M | +9.0% |
| R&D Expense | $90.7M | +16.0% |
| SG&A Expense | $76.5M | +9.5% |
| Operating Income | $82.4M | +17.1% |
| Pre-tax Income | $54.3M | +22.4% |
| Income Tax | $23.3M | +11.5% |
| Net Income | $31.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.2M | -44.3% |
| Accounts Receivable | $44.9M | +12.2% |
| Current Assets | $183.9M | -18.2% |
| Total Assets | $1.34B | +15.1% |
| Current Liabilities | $150.1M | +83.7% |
| Long-term Debt | $333.1M | -0.6% |
| Total Liabilities | $579.6M | +28.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $79.4M | -11.8% |
| Capital Expenditures | $17.6M | +27.5% |
| Investing Cash Flow | -$122.4M | -448.1% |
| Financing Cash Flow | -$22.6M | -48.9% |
| Free Cash Flow | $61.9M | -18.9% |
| +32.2% |
| EPS (Basic) | $0.17 | +30.8% |
| EPS (Diluted) | $0.16 | +23.1% |
| Stockholders' Equity |
| $759.3M |
| +6.7% |